Clinical Trial Update: Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating absorption, metabolism, and excretion of radiolabeled pamiparib in participants with advanced cancer completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• [14C]-Pamiparib (pamiparib)

Snippet

Sponsor: BeiGene | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-09-27